This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ortiz, P. A. Articles by Garvin, J. L. Search for Related Content PubMed PubMed Citation Articles by Ortiz, P. A. Articles by Garvin, J. L. Related Collections Cardio-renal physiology/pathophysiology

(Hypertension. 2001;37:467.)
© 2001 American Heart Association, Inc.

Scientific Contributions

NO Inhibits NaCl Absorption by Rat Thick Ascending Limb Through Activation of cGMP-Stimulated Phosphodiesterase

Pablo A. Ortiz; Jeffrey L. Garvin

From the Division of Hypertension and Vascular Research, Henry Ford Hospital, Detroit, Mich.

Correspondence to Jeffrey L. Garvin, PhD, Division of Hypertension and Vascular Research, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202. E-mail jgarvin1{at}hfhs.org

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
In the isolated, perfused rat thick ascending limb (THAL), L-arginine (L-Arg) stimulates endogenous nitric oxide (NO) production, which inhibits NaCl absorption. However, the intracellular cascade responsible for the effects of NO has not been studied. We hypothesized that endogenous NO inhibits THAL NaCl transport by increasing cGMP, which activates protein kinase G (PKG) and cGMP-stimulated phosphodiesterase (PDE II), which, in turn, decreases cAMP levels. THALs from rats were isolated and perfused, and net chloride flux (J_Cl-) was measured. L-Arg was used to stimulate NO production. Adding L-Arg (0.5 mmol/L) to the bath decreased J_Cl- from 154.4±9.9 to 101.9±14.1 pmol · mm^-1 · min^-1, a 35.2% decrease (n=6; P<0.05). In the presence of the soluble guanylate cyclase inhibitor LY-83583 (10 µmol/L), adding L-Arg to the bath did not affect THAL J_Cl- (143.7±28.1 versus 136.7±22.2 pmol · mm^-1 · min^-1; n=6). LY-83583 alone had no effect on J_Cl-. In the presence of the PDE II inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) 50 µmol/L, L-Arg reduced J_Cl- by only 13% (142.1±8.9 versus 122.7±11.5 pmol · mm^-1 · min^-1; P<0.05; n=6). EHNA alone had no effect on THAL J_Cl-. In the presence of 10^-5 mol/L dibutyryl (db)-cAMP, L-Arg did not significantly reduce J_Cl- (116.3±18.2 versus 102.6±15.6 pmol · mm^-1 · min^-1; n=6). db-cAMP (10^-5 mol/L) had no effect on THAL J_Cl-. In the presence of the PKG inhibitor KT-5823 (2 µmol/L), L-Arg lowered J_Cl- from 142.6±14.1 to 85.9±8.3 pmol · mm^-1 · min^-1, a decrease of 35.6% (n=8; P<0.05). We conclude that (1) endogenous NO inhibits THAL J_Cl- by stimulating soluble guanylate cyclase and increasing cGMP; (2) NO inhibits THAL J_Cl- by stimulation of PDE II, which, in turn, decreases cAMP levels; and (3) PKG does not mediate NO-induced inhibition of THAL J_Cl-.

Key Words: limb, thick, ascending • nitric oxide • cGMP • phosphodiesterases • transport, chloride

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
Several studies have demonstrated that nitric oxide (NO) exerts natriuretic effects in vivo.^{1 2} In vitro, NO inhibits transport in the proximal tubule,^{3 4} cortical collecting duct,⁵ and inner medullary collecting duct.⁶ We previously reported that endogenously produced NO inhibits chloride absorption in isolated, perfused thick ascending limbs (THAL).⁷

Both cGMP-dependent and cGMP-independent mechanisms mediate NO effects in different tissues.^{8 9 10} However, in vivo studies suggest that the natriuretic and diuretic effects of NO are mediated by cGMP.^{11 12} In vitro studies demonstrated that NO increases cGMP production in the proximal tubule and cortical collecting duct.^{3 13} Using isolated THALs, we¹⁴ and other investigators¹⁵ have shown that NO donors stimulate production of cGMP. However, the cascade beyond cGMP has not been studied in the THAL.

cGMP can alter the activity of several enzymes, including protein kinase G (PKG) and cGMP-stimulated and cGMP-inhibited phosphodiesterases (PDE II and PDE III, respectively).¹⁶ In cardiac myocytes¹⁷ and platelets,¹⁸ nitric oxide (NO) prevents the effects of cAMP through activation of PDE II. In the isolated perfused cortical collecting duct, NO inhibits arginine vasopressin–stimulated osmotic water permeability by decreasing cAMP production through activation of PKG.¹³ Because hormones that increase cAMP production stimulate chloride absorption in the THAL,^{19 20} we hypothesize that endogenously produced NO inhibits THAL chloride absorption by stimulating soluble guanylate cyclase, which increases cGMP, thus activating PKG and PDE II and thereby decreasing cAMP.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
THAL Isolation and Perfusion
THALs were obtained from male Sprague-Dawley rats weighing 120 to 150 g (Charles River Breeding Laboratories, Wilmington, Mass) maintained on a diet that contained 0.22% sodium and 1.1% potassium (Ralston Purina) for 5 days. Each rat was anesthetized with ketamine 100 mg/kg body wt and xylazine 20 mg/kg body wt. The abdominal cavity was opened and flushed with ice-cold 150 mmol/L NaCl. The left kidney was removed and bathed in ice-cold perfusion solution. Coronal slices were cut and THALs dissected from medullary rays and perfused at 37°C as described previously.²¹ All protocols were performed in accordance with the guidelines of the Henry Ford Hospital Animal Care and Use Committee.

In all experiments, both lumen and bath contained (in mmol/L) 114 NaCl, 25 NaHCO₃, 2.5 NaH₂PO₄, 4 KCl, 1.2 MgSO₄, 6 alanine, 1 trisodium citrate, 5.5 glucose, and 2 calcium dilactate. All solutions were gassed with 95% O₂/5% CO₂ before the experiment. Osmolality of the solution was 290±3 mOsmol/kg H₂O as measured by freezing-point depression, pH 7.4. The basolateral bath was exchanged at a rate of 0.5 mL/min by means of a continuously flowing exchange system, and tubules were perfused at 5 to 10 nL · mm^-1 · min^-1.

L-Arginine (L-Arg) was added to the bath to stimulate endogenous NO production. We tested the effects of L-Arg (Sigma Chemical Co) on chloride absorption by isolated perfused THALs alone and in the presence of the soluble guanylate cyclase inhibitor LY-83583 (Biomol), PKG inhibitor KT-5823 (Biomol), phosphodiesterase II inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) (Biomol) and membrane-permeable cyclic nucleotide analogues dibutyryl-cGMP (db-cGMP) and dibutyryl-cAMP (db-cAMP) (Sigma). Typically, tubules were equilibrated for 20 to 25 minutes in the presence of each inhibitor at 37°C, and 4 measurements corresponding to basal reabsorption rates were taken. L-Arg was then added to the bath, and after a 20-minute reequilibration period, 4 additional collections were made. In control experiments, we determined the effect of each inhibitor alone on THAL chloride absorption. Additionally, time-control experiments were performed in the presence of each inhibitor.

Chloride concentration in the perfusate and collected fluid was measured by microfluorometry.²² All data were recorded and stored on data acquisition software (DATAQ Instruments). Data analysis was performed with newly developed software specifically designed for voltage-spike analysis.

Statistics
Results are expressed as mean±SE. Differences between means were evaluated with Student’s paired t test. P<0.05 was considered significant.

	Results

Top Abstract Introduction Methods Results Discussion References

 
Because we were interested in studying the second-messenger cascade activated by endogenously produced NO, we first tested the effects of L-Arg (0.5 mmol/L) on THAL chloride absorption (J_Cl-). In isolated perfused THALs, addition of L-Arg (0.5 mmol/L) to the basolateral bath significantly decreased J_Cl- from 154.4±9.9 to 101.9±14 pmol · mm^-1 · min^-1. Time controls showed no reduction in chloride absorption over a 2-hour period. Thus, the presence of 0.5 mmol/L L-Arg in the bath significantly decreased THAL chloride absorption, by 36.9±11.6% (P<0.025, n=6; Figure 1).

View larger version (13K): [in this window] [in a new window]   Figure 1. Effect of L-Arg on THAL JCl-. Addition of 0.5 mmol/L L-Arg to the bath decreased THAL JCl- by 36.9±11.6% (*P<0.05; n=6).

In many cell types, including tubular epithelial cells, NO stimulates soluble guanylate cyclase.^{3 14 23} To determine whether endogenous NO inhibits THAL chloride absorption by stimulating soluble guanylate cyclase, we tested whether LY-83583, a soluble guanylate cyclase inhibitor, could block the effects of L-Arg on THAL J_Cl-. In the presence of LY-83583 (10 µmol/L), chloride absorption averaged 143.7±28.1 pmol · mm^-1 · min^-1. After 0.5 mmol/L L-Arg was added to the bath, chloride absorption was 136.7±22.2 pmol · mm^-1 · min^-1 (Figure 2). Control experiments showed that blocking soluble guanylate cyclase with LY-83583 did not modify basal THAL J_Cl- (n=7). These results indicate that the effect of L-Arg on THAL J_Cl- is mediated by stimulation of soluble guanylate cyclase.

View larger version (16K): [in this window] [in a new window]   Figure 2. Effect of L-Arg on THAL JCl- during soluble guanylate cyclase (sGC) blockade. In the presence of the sGC inhibitor LY-83583 (10 µmol/L), addition of 0.5 mmol/L L-Arg to the bath did not change THAL JCl-.

LY-83583 has been reported to have effects other than inhibition of soluble guanylate cyclase.²⁴ Therefore, we studied whether the effects of L-Arg and cGMP are additive. In the presence of 50 µmol/L db-cGMP, chloride absorption averaged 132.7±17.1 pmol · mm^-1 · min^-1. After L-Arg 0.5 mmol/L was added to the bath, THAL J_Cl- did not change significantly (n=6). Control experiments in the presence of db-cGMP showed no significant change in THAL J_Cl- over time (n=4). Taken together, these data indicate that cGMP mediates all of the effects of NO on THAL J_Cl-.

cGMP may activate either PKG or the cGMP-dependent phosphodiesterases, PDE II and PDE III.¹⁶ Stimulation of PDE II decreases intracellular levels of cAMP,²⁵ which is known to stimulate THAL chloride transport.¹⁹ To test whether inhibition of PDE II activity could block the effects of L-Arg, we used the PDE II inhibitor EHNA. During incubation with EHNA 50 µmol/L, chloride absorption averaged 142.1±8.9 pmol · mm^-1 · min^-1. After L-Arg 0.5 mmol/L was added to the bath, THAL J_Cl- was 122.7±11.5 pmol · mm^-1 · min^-1, a 13% decrease (Figure 3). Adding EHNA (50 µmol/L) alone to the bath did not change THAL J_Cl- (n=4). Time-control experiments in the presence of EHNA (50 µmol/L) showed no significant change in THAL J_Cl- (n=4). These data show that PDE II inhibition blunts L-Arg-induced inhibition of THAL transport.

View larger version (16K): [in this window] [in a new window]   Figure 3. Effect of L-Arg on THAL JCl- during PDE II blockade. In the presence of the PDE II inhibitor EHNA (50 µmol/L), addition of 0.5 mmol/L L-Arg to the bath decreased THAL JCl- by only 13% (*P<0.05; n=6).

Because activation of PDE II mediates the effects of NO, we next tested whether we could block the effects of L-Arg by treating tubules with a cAMP analogue not hydrolyzed by PDE II.²⁵ For this purpose, we performed dose-response experiments to determine the maximum concentration of db-cAMP that does not stimulate transport by itself and used it in the following experiments. In the presence of db-cAMP 10^-5 mol/L, chloride absorption averaged 116.3±18.2 pmol · mm^-1 · min^-1. After L-Arg 0.5 mmol/L was added to the bath, THAL J_Cl- did not change significantly (n=6; Figure 4). Time-control experiments in the presence of db-cAMP 10^-5 mol/L showed no significant change in THAL J_Cl- during the experimental period (n=4). These results indicate that preventing the fall in intracellular cAMP blocks NO-induced inhibition of chloride absorption.

View larger version (15K): [in this window] [in a new window]   Figure 4. Effect of L-Arg on THAL JCl- during incubation with a 10-5 mol/L db-cAMP. In the presence of a nonstimulatory concentration of db-cAMP, addition of 0.5 mmol/L L-Arg to the bath did not significantly alter THAL JCl- (n=6).

Because activation of PKG decreases cAMP in the cortical collecting duct,¹³ we determined whether PKG activation is a necessary step in the NO second messenger cascade. For this purpose we tested the effect of L-Arg 0.5 mmol/L on THAL J_Cl- in the presence of KT-5823, a PKG inhibitor. During incubation with KT-5823 2 µmol/L, THAL J_Cl- averaged 142.6±14.1 pmol · mm^-1 · min^-1. As shown in Figure 5, addition of L-Arg 0.5 mmol/L to the bath significantly decreased chloride absorption to 85.9±8.3 pmol · mm^-1 · min^-1, a 35.6% decrease (n=8; P<0.05). These results indicate that PKG does not play a major role in the NO-induced inhibition of J_Cl-.

View larger version (15K): [in this window] [in a new window]   Figure 5. Effect of L-Arg on THAL JCl- during PKG inhibition. In the presence of the PKG inhibitor KT-5823 (2 µmol/L), addition of 0.5 mmol/L L-Arg to the bath significantly decreased THAL JCl-, by 35.6% (*P<0.05; n=8).

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
In many cell types, NO activates soluble guanylate cyclase and increases cGMP production.^{3 10} Our data show that inhibition of THAL soluble guanylate cyclase completely blocks NO-induced inhibition of THAL chloride absorption and that the effects of NO and cGMP on chloride absorption are not additive. Taken together, these data indicate that NO stimulates soluble guanylate cyclase and increases cGMP. This, in turn, mediates all of the effects of NO on THAL chloride transport. Our results are consistent with others showing that cGMP inhibits transport in the THAL and other nephron segments.^{26 27} The NO donor spermine NONOate increases cGMP production in the cortical collecting duct¹³ while sodium nitroprusside (SNP) increases cGMP production in the proximal tubule, and this effect is blocked by inhibiting soluble guanylate cyclase with LY-83583.³ Although we know of no reports regarding the amount of soluble guanylate cyclase enzyme present in the THAL, Terada et al²⁸ found reverse transcription PCR products for soluble guanylate cyclase in microdissected THALs. In agreement with the presence of soluble guanylate cyclase in the THAL, we¹⁴ and others¹⁵ have reported an increase in cGMP production after incubation of THALs with NO donors.

It has been reported that NO can exert its effects by cGMP-dependent and cGMP-independent mechanisms. cGMP-dependent mechanisms are mediated by phosphodiesterases, PKG, and cGMP-gated ion channels.¹⁶ cGMP-independent mechanisms include K⁺ channel activation,⁸ modification of sulfhydryl groups,²⁹ and changes in intracellular calcium.⁹ We found that NO-induced inhibition of chloride absorption is completely mediated by cGMP. However, our data do not rule out the possibility that NO can affect other physiological functions directly.

Hormones that increase cAMP production stimulate THAL chloride absorption.^{19 20} cGMP can interact with the cAMP pathway by modulating the activity of 2 different phosphodiesterases. PDE II is stimulated by cGMP to break down both cAMP and cGMP.³⁰ PDE III is inhibited by cGMP, and it mainly degrades cAMP.¹⁶ Because NO inhibits THAL J_Cl- and cAMP stimulates THAL J_Cl-, activation of PDE III is not likely to mediate the effects of NO in the THAL. Therefore, we tested whether the effects of NO are mediated by activation of PDE II. When PDE II was inhibited by EHNA, L-Arg only produced a small reduction in J_Cl-, which indicated that the effect of NO on chloride absorption is mediated mainly by activation of this enzyme. Researchers have reported that part of the effect of NO on platelet aggregation is mediated by stimulation of PDE II and can be prevented by treatment with EHNA.¹⁸ In isolated cardiac myocytes, activation of PDE II mediates the effect of NO on L-type Ca²⁺ channels.^{17 31} Velardez et al³² found that the NO-induced inhibition of prolactin release from the pituitary gland is caused by a reduction of cAMP that can be prevented by blocking PDE II.

The fact that EHNA does not completely block the effect of L-Arg could be due to failure of EHNA to inhibit the enzyme completely. The inhibitory effect of EHNA has been reported to be achieved by competition of EHNA with cAMP for the catalytic site of PDE II.³³ Therefore, it is possible that at 50 µmol/L, enzyme catalysis was not completely inhibited. Concentrations of EHNA >80 µmol/L have been reported to inhibit other families of PDE enzymes.^{17 34} Thus, to avoid misinterpretation of the results, we did not test concentrations >50 µmol/L. EHNA is also known to inhibit adenosine deaminase. However, we found no effect of EHNA on chloride transport in control experiments. In addition, inhibition of adenosine deaminase increases adenosine content and inhibits THAL J_Cl-.³⁵ Because EHNA blunts NO-induced inhibition of J_Cl-, inhibition of adenosine deaminase by EHNA is unlikely to have affected our results.

Activation of PDE II by cGMP may cause a decrease in cAMP levels in the THAL as it does in other cells.^{18 25 32} To test whether a decrease in cAMP is necessary for NO-induced inhibition of THAL J_Cl-, we treated tubules with a cAMP analogue that is not hydrolyzed by PDE II.²⁵ Our results show that a nonstimulatory concentration of db-cAMP prevented the effects of L-Arg. Our results are supported by De Jesus Ferreira and Bailly,³⁶ who showed that under basal conditions, with no stimulation of cAMP, inhibition of protein kinase A decreases basal chloride absorption in the THAL.

cGMP can exert intracellular effects by interacting with PKG.³⁷ In cortical collecting ducts, the inhibitory effect of NO on arginine vasopressin–stimulated osmotic water permeability is mediated by stimulation of PKG, which also decreases cAMP.¹³ In the proximal tubule, ANP inhibits fluid reabsorption by stimulation of PKG.³⁸ Our results show that blockade of PKG had no effect on NO-induced inhibition of chloride absorption, which indicates that PKG does not mediate the effects of NO on THAL chloride transport. It is unlikely that the concentration of KT-5823 we used is not sufficient to inhibit PKG. First, we used a KT-5823 concentration that is 10 times the inhibition constant for PKG inhibition. Second, we recently reported that NO-induced inhibition of THAL bicarbonate transport is mediated by PKG activation, because 2 µmol/L KT-5823 blocked the effect.³⁹

In summary, we conclude that (1) endogenous NO inhibits THAL chloride absorption by stimulating soluble guanylate cyclase and increasing cGMP; (2) NO inhibits THAL J_Cl- by stimulation of PDE II, which, in turn, decreases cAMP levels; and (3) PKG does not mediate NO-induced inhibition of THAL chloride transport.

	Acknowledgments

 
This work was supported in part by a grant from the National Institutes of Health (HL-28982).

Received October 24, 2000; first decision December 8, 2000; accepted December 18, 2000.

	References

Top Abstract Introduction Methods Results Discussion References

 
1. Lahera V, Salom MG, Miranda-Guardiola F, Moncada S, Romero JC. Effects of N-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol. 1991;261:F1033–F1037.[Abstract/Free Full Text]

2. Majid DSA, Williams A, Kadowitz PJ, Navar LG. Renal responses to intra-arterial administration of nitric oxide donors in dogs. Hypertension. 1993;22:535–541.[Abstract/Free Full Text]

3. Roczniak A, Burns K. Nitric oxide stimulates guanylate cyclase and regulates sodium transport in rabbit proximal tubule. Am J Physiol. 1996;270:F106–F115.[Abstract/Free Full Text]

4. Eitle E, Hiranyachattada S, Wang H, Harris P. Inhibition of proximal tubular fluid absorption by nitric oxide and atrial natriuretic peptide in rat kidney. Am J Physiol. 1998;274:C1075–C1080.

5. Stoos BA, Garcia NH, Garvin JL. Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. J Am Soc Nephrol. 1995;6:89–84.[Abstract]

6. Zeidel ML, Deepak K, Silava P, Burrowes M, Brenner BM. Atrial natriuretic peptides inhibit conductive sodium uptake by rabbit inner medullary collecting duct. J Clin Invest. 1988;82:1067–1074.

7. Plato CF, Stoos BA, Wang D, Garvin JL. Endogenous nitric oxide inhibits chloride transport in the thick ascending limb. Am J Physiol. 1999;276:F159–F163.[Abstract/Free Full Text]

8. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen R. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850–853.[Medline] [Order article via Infotrieve]

9. Weisbrod RM, Griswold MC, Yaghoubi M, Komalavilas P, Lincoln TM, Cohen R. Evidence that additional mechanisms to cyclic GMP mediate the decrease in intracellular calcium and relaxation of rabbit aortic smooth muscle to nitric oxide. Br J Pharmacol. 1998;125:1695–1707.[Medline] [Order article via Infotrieve]

10. Furchgott RF. Studies on endothelium-dependent vasodilation and the endothelium-derived relaxing factor. Acta Physiol Scand. 1990;139:257–270.[Medline] [Order article via Infotrieve]

11. Lahera V, Navarro J, Biondi ML, Ruilope LM, Romero JC. Exogenous cGMP prevents decrease in diuresis and natriuresis induced by inhibition of NO synthesis. Am J Physiol. 1993;264:F344–F347.[Abstract/Free Full Text]

12. Grandes S, Gallego MJ, Riesco A, Lopez Farre A, Millas I, Casado S, Hernando L, Caramelo C. Mechanisms of renal effects of different agents stimulating production of cGMP. Am J Physiol. 1991;261:H1109–H1114.[Abstract/Free Full Text]

13. Garcia NH, Stoos BA, Carretero OA, Garvin JL. Mechanism of the nitric oxide-induced blockade of collecting duct water permeability. Hypertension. 1996;27(pt 2):679–683.

14. Garcia NH, Plato CF, Stoos BA, Garvin JL. Nitric oxide-induced inhibition of transport by thick ascending limbs from Dahl salt-sensitive rats. Hypertension. 1999;34:508–513.[Abstract/Free Full Text]

15. Lu M, Wang X, Wang W. Nitric oxide increases the activity of the apical 70-pS K⁺ channel in TAL of rat kidney. Am J Physiol. 1998;274:F946–F950.[Abstract/Free Full Text]

16. MacFarland RT. Molecular aspects of cyclic GMP signaling. Zoological Sci. 1995;12:151–163.[Medline] [Order article via Infotrieve]

17. Mery PF, Pavoine C, Pecker F, Fischmeister R. Erythro-9-(2-Hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes. Mol Pharmacol. 1995;48:121–130.[Abstract]

18. Dickinson NT, Jang EK, Haslam J. Activation of cGMP-stimulated phosphodiesterase by nitroprusside limits cAMP accumulation in human platelets: effects on platelet aggregation. Biochem J. 1997;323:371–377.

19. Hebert SC, Andreoli TE. Control of NaCl transport in the thick ascending limb. Am J Physiol. 1984;246:F745–F756.[Abstract/Free Full Text]

20. Hall DA, Varney DM. Effect of vasopressin on electrical potential difference and chloride transport in mouse medullary thick ascending limb of Henle’s loop. J Clin Invest. 1980;66:792–802.

21. Garvin JL, Burg MB, Knepper MA. Active NH₄⁺ absorption by the thick ascending limb. Am J Physiol. 1988;255:F57–F65.[Abstract/Free Full Text]

22. Garcia NH, Plato CF, Garvin JL. Fluorescent determination of chloride in nanoliter samples. Kidney Int. 1999;55:321–325.[Medline] [Order article via Infotrieve]

23. Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol. 1991;41:485–490.[Medline] [Order article via Infotrieve]

24. Kontos HA, Wei EP. Hydroxyl radical-dependent inactivation of guanylate cyclase in cerebral arterioles by methylene blue and by LY83583. Stroke. 1993;24:427–434.[Abstract/Free Full Text]

25. MacFarland RT, Zelus BD, Beavo JA. High concentrations of a cGMP-stimulated phosphodiesterase mediate ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells. J Biol Chem. 1991;266:136–142.[Abstract/Free Full Text]

26. Neant F, Bailly C. Luminal and intracellular cGMP inhibit the mTAL reabsorptive capacity through different pathways. Kidney Int. 1993;44:741–746.[Medline] [Order article via Infotrieve]

27. Garvin JL. Inhibition of J_v by ANF in rat proximal straight tubules requires angiotensin. Am J Physiol. 1989;257:F907–F911.[Abstract/Free Full Text]

28. Terada Y, Tomita K, Nonoguchi H, Marumo F. Polymerase chain reaction localization of constitutive nitric oxide synthase and soluble guanylate cyclase messenger RNAs in microdissected rat nephron segments. J Clin Invest. 1992;90:659–665.

29. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell. 1994;78:931–936.[Medline] [Order article via Infotrieve]

30. Stroop SD, Beavo JA. Structure and function studies of the cGMP-stimulated phosphodiesterase. J Biol Chem. 1991;266:23802–23809.[Abstract/Free Full Text]

31. Ji GJ, Fleischmann BK, Bloch W, Feelisch M, Andressen C, Addicks K, Hescheler J. Regulation of the L-type Ca²⁺ channel during cardiomyogenesis: switch from NO to adenylyl cyclase-mediated inhibition. FASEB J. 1999;13:313–324.[Abstract/Free Full Text]

32. Velardez MO, De Laurentiis A, Diaz MC, Lasaga M, Pisera D, Seilicovich A, Duvilanski BH. Role of phosphodiesterase and protein kinase G on nitric oxide-induced inhibition of prolactin release from the rat anterior pituitary. Eur J Endocrinol. 2000;143:279–284.[Abstract]

33. Hynes J, Killilea DW, Peterson PD, Thompson JW. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3',5'-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung. J Pharmacol Exp Ther. 1996;276:752–757.[Abstract/Free Full Text]

34. Podzuweit T, Nennstiel P, Muller A. Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterase by erythro-9-(2-Hydroxy-3-nonyl)adenine. Cell Signal. 1995;7:733–738.[Medline] [Order article via Infotrieve]

35. Beach RE, Good DW. Effects of adenosine on ion transport in rat medullary thick ascending limb. Am J Physiol. 1992;263:F482–F487.[Abstract/Free Full Text]

36. De Jesus Ferreira MC, Bailly C. Extracellular Ca²⁺ decreases chloride reabsorption in rat CTAL by inhibiting cAMP pathway. Am J Physiol. 1998;275:F198–F203.

37. Lincoln TH, Corbin JD. Characterization and biological role of the cGMP-dependent protein kinase. In: Greengard P, Robinson GA, eds. Advances in Cyclic Nucleotide Research. Vol 15. New York, NY: Raven Press; 1983:139–192.

38. Garcia NH, Garvin JL. ANF and angiotensin II interact via kinases in the proximal straight tubule. Am J Physiol. 1995;268:F730–F735.[Abstract/Free Full Text]

39. Ortiz PA, Garvin JL. Autocrine effects of nitric oxide on HCO₃^- transport by rat thick ascending limbs. Kidney Int. 2000;58:2069–2074.[Medline] [Order article via Infotrieve]

This article has been cited by other articles:

				N. J. Hong and J. L. Garvin Nitric oxide reduces flow-induced superoxide production via cGMP-dependent protein kinase in thick ascending limbs Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1061 - F1066. [Abstract] [Full Text] [PDF]

				V. D. Ramseyer and J. L. Garvin Angiotensin II Decreases Nitric Oxide Synthase 3 Expression via Nitric Oxide and Superoxide in the Thick Ascending Limb Hypertension, February 1, 2009; 53(2): 313 - 318. [Abstract] [Full Text] [PDF]

				P.-C. Chao and K. L. Hamilton Genistein stimulates electrogenic Cl- secretion via phosphodiesterase modulation in the mouse jejunum Am J Physiol Cell Physiol, January 1, 2009; 297(3): C688 - C698. [Abstract] [Full Text] [PDF]

				C. S. Wilcox and A. Pearlman Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides Pharmacol. Rev., December 1, 2008; 60(4): 418 - 469. [Abstract] [Full Text] [PDF]

				G. R. Ares, P. Caceres, F. J. Alvarez-Leefmans, and P. A. Ortiz cGMP decreases surface NKCC2 levels in the thick ascending limb: role of phosphodiesterase 2 (PDE2) Am J Physiol Renal Physiol, October 1, 2008; 295(4): F877 - F887. [Abstract] [Full Text] [PDF]

				Y. Ren, M. A. D'Ambrosio, H. Wang, R. Liu, J. L. Garvin, and O. A. Carretero Heme oxygenase metabolites inhibit tubuloglomerular feedback (TGF) Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1207 - F1212. [Abstract] [Full Text] [PDF]

				M. Herrera, P. A. Ortiz, and J. L. Garvin Regulation of thick ascending limb transport: role of nitric oxide Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1279 - F1284. [Abstract] [Full Text] [PDF]

				G. Silva, W. H. Beierwaltes, and J. L. Garvin Extracellular ATP Stimulates NO Production in Rat Thick Ascending Limb Hypertension, March 1, 2006; 47(3): 563 - 567. [Abstract] [Full Text] [PDF]

				C. S. Wilcox Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R913 - R935. [Abstract] [Full Text] [PDF]

				M. Herrera and J. L. Garvin A high-salt diet stimulates thick ascending limb eNOS expression by raising medullary osmolality and increasing release of endothelin-1 Am J Physiol Renal Physiol, January 1, 2005; 288(1): F58 - F64. [Abstract] [Full Text] [PDF]

				P. A. Ortiz, N. J. Hong, and J. L. Garvin Luminal flow induces eNOS activation and translocation in the rat thick ascending limb. II. Role of PI3-kinase and Hsp90 Am J Physiol Renal Physiol, August 1, 2004; 287(2): F281 - F288. [Abstract] [Full Text] [PDF]

				J. Zimpelmann, N. Li, and K. D. Burns Nitric oxide inhibits superoxide-stimulated urea permeability in the rat inner medullary collecting duct Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1160 - F1167. [Abstract] [Full Text]

				G. Kovacs, P. Komlosi, A. Fuson, J. Peti-Peterdi, L. Rosivall, and P. D. Bell Neuronal Nitric Oxide Synthase: Its Role and Regulation in Macula Densa Cells J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2475 - 2483. [Abstract] [Full Text] [PDF]

				P. A. Ortiz, N. J. Hong, D. Wang, and J. L. Garvin Gene Transfer of eNOS to the Thick Ascending Limb of eNOS-KO Mice Restores the Effects of L-Arginine on NaCl Absorption Hypertension, October 1, 2003; 42(4): 674 - 679. [Abstract] [Full Text] [PDF]

				H. He, T. Podymow, J. Zimpelmann, and K. D. Burns NO inhibits Na+-K+-2Cl- cotransport via a cytochrome P-450-dependent pathway in renal epithelial cells (MMDD1) Am J Physiol Renal Physiol, June 1, 2003; 284(6): F1235 - F1244. [Abstract] [Full Text] [PDF]

				P. A. Ortiz and J. L. Garvin Cardiovascular and renal control in NOS-deficient mouse models Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R628 - R638. [Abstract] [Full Text] [PDF]

				P. Ortiz, B. A. Stoos, N. J. Hong, D. M. Boesch, C. F. Plato, and J. L. Garvin High-Salt Diet Increases Sensitivity to NO and eNOS Expression But Not NO Production in THALs Hypertension, March 1, 2003; 41(3): 682 - 687. [Abstract] [Full Text] [PDF]

				T. L. Pallone, Z. Zhang, and K. Rhinehart Physiology of the renal medullary microcirculation Am J Physiol Renal Physiol, February 1, 2003; 284(2): F253 - F266. [Abstract] [Full Text] [PDF]

				P. A. Ortiz and J. L. Garvin Superoxide stimulates NaCl absorption by the thick ascending limb Am J Physiol Renal Physiol, November 1, 2002; 283(5): F957 - F962. [Abstract] [Full Text] [PDF]

				R. Liu, R. Wu, J. Flammer, and I. O. Haefliger Inhibition by Brimonidine of Forskolin-Induced Nitrite Production in Isolated Pig Ciliary Processes Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2727 - 2731. [Abstract] [Full Text] [PDF]

				P. A. Ortiz and J. L. Garvin Role of nitric oxide in the regulation of nephron transport Am J Physiol Renal Physiol, May 1, 2002; 282(5): F777 - F784. [Abstract] [Full Text] [PDF]

				T. Chabrashvili, A. Tojo, M. L. Onozato, C. Kitiyakara, M. T. Quinn, T. Fujita, W. J. Welch, and C. S. Wilcox Expression and Cellular Localization of Classic NADPH Oxidase Subunits in the Spontaneously Hypertensive Rat Kidney Hypertension, February 1, 2002; 39(2): 269 - 274. [Abstract] [Full Text] [PDF]

				P. A. Ortiz and J. L. Garvin Interaction of O2- and NO in the Thick Ascending Limb Hypertension, February 1, 2002; 39(2): 591 - 596. [Abstract] [Full Text] [PDF]

				P. A. Ortiz, N. J. Hong, and J. L. Garvin NO decreases thick ascending limb chloride absorption by reducing Na+-K+-2Cl- cotransporter activity Am J Physiol Renal Physiol, November 1, 2001; 281(5): F819 - F825. [Abstract] [Full Text] [PDF]

				C. F. Plato and J. L. Garvin alpha 2-Adrenergic-mediated tubular NO production inhibits thick ascending limb chloride absorption Am J Physiol Renal Physiol, October 1, 2001; 281(4): F679 - F686. [Abstract] [Full Text] [PDF]

				C. F. Plato {alpha}-2 And {beta}-adrenergic receptors mediate NE's biphasic effects on rat thick ascending limb chloride flux Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R979 - R986. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ortiz, P. A. Articles by Garvin, J. L. Search for Related Content PubMed PubMed Citation Articles by Ortiz, P. A. Articles by Garvin, J. L. Related Collections Cardio-renal physiology/pathophysiology